Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030193 (
pain
)
261,466
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Persistent somatoform pain disorder
is a mental disease the symptom of which--namely, physical
pain
--cannot be satisfactorily explained by physical findings. This is a frequently occurring disease. But it is often not identified or at least not recognised at an early stage. This leads to negative effects on the patient (e.g. chronification) and on the national social welfare system (for example, costs can mount up to thousands of million DM for medical and social welfare measures). To reduce these problems as far as possible, it is imperative to recognise the disease at an early stage. In particular, those doctors who are mainly engaged in the medical treatment of organs must be familiar with the possibility of functional
pain
arising from psychic factors, and they must be able to identify it in individual cases, at least as a tentative diagnosis.
...
PMID:[Social medicine aspects of persistent somatoform pain disorder]. 128 52
Persistent somatoform pain disorder
(
PSPD
) is a mental disorder un-associated with any somatic injury and can cause severe somatosensory and emotional impairments in patients. However, so far, the neuro-pathophysiological mechanism of the functional impairments in
PSPD
is still unclear. The present study assesses the difference in regional spontaneous activity between
PSPD
and healthy controls (HC) during a resting state, in order to elucidate the neural mechanisms underlying
PSPD
. Resting-state functional Magnetic Resonance Imaging data were obtained from 13
PSPD
patients and 23 age- and gender-matched HC subjects in this study. Kendall's coefficient of concordance was used to measure regional homogeneity (ReHo), and a two-sample t-test was subsequently performed to investigate the ReHo difference between
PSPD
and HC. Additionally, the correlations between the mean ReHo of each survived area and the clinical assessments were further analyzed. Compared with the HC group, patients with
PSPD
exhibited decreased ReHo in the bilateral primary somatosensory cortex, posterior cerebellum, and occipital lobe, while increased ReHo in the prefrontal cortex (PFC) and default mode network (including the medial PFC, right inferior parietal lobe (IPL), and left supramarginal gyrus). In addition, significant positive correlations were found between the mean ReHo of both right IPL and left supramarginal gyrus and participants' Self-Rating Anxiety Scale (SAS) scores, and between the mean ReHo of the left middle frontal gyrus and Visual Analogue Scale (VAS) scores. Our results suggest that abnormal spontaneous brain activity in specific brain regions during a resting state may be associated with the dysfunctions in
pain
, memory and emotional processing commonly observed in patients with
PSPD
. These findings help us to understand the neural mechanisms underlying
PSPD
and suggest that the ReHo metric could be used as a clinical marker for
PSPD
.
...
PMID:Altered Spontaneous Activity in Patients with Persistent Somatoform Pain Disorder Revealed by Regional Homogeneity. 2697 2